Similarly, gene and cell therapies are beyond the purpose of this review and have been discussed in other recent publications [8, 9]
Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
In the SUSTAIN 8 trial, once-weekly add-on subcutaneous semaglutide was compared with add-on canagliflozin [18]
Bragadin M, Marton D, Manente S, Grasso M, Toninello A (2002) Methylmercury induces the opening of the permeability transition pore in rat liver mitochondria
The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial
Bupropion contribution to weight loss is modest and gradual, often not noticeable independently against the more dramatic tirzepatide effect